Related Experiment Video
Updated: Jan 20, 2026
07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.9K
Morbid Obesity as a Therapeutic Target for Heart Failure
1Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH, 44195, USA. albertc2@ccf.org.
Current Treatment Options in Cardiovascular Medicine
|September 6, 2019
Summary
Treating morbid obesity in heart failure patients is crucial. Bariatric surgery shows promise for improving heart failure symptoms and potentially reducing the need for cardiac transplantation.
Area of Science:
- Cardiology
- Bariatric Medicine
- Obesity Medicine
Background:
- Morbid obesity is increasingly recognized as a significant comorbidity in patients with heart failure syndromes.
- The dual diagnosis presents unique clinical challenges and necessitates a comprehensive treatment approach.
Purpose of the Study:
- To define morbid obesity and its relationship with heart failure.
- To explore the challenges in managing patients with coexisting heart failure and morbid obesity.
- To evaluate the evidence supporting obesity as a therapeutic target in heart failure management.
Main Methods:
- This review synthesizes emerging literature on the impact of obesity treatment in heart failure patients.
- Analysis of data on the safety and efficacy of interventions, particularly surgical weight loss.
Main Results:
- Emerging evidence indicates that surgical weight loss is safe and effective in heart failure patients.
- Bariatric surgery is associated with improved heart failure symptoms and reverse cardiac remodeling.
- In advanced heart failure, bariatric surgery can obviate or facilitate cardiac transplantation.
Conclusions:
- Obesity management is a vital therapeutic target for patients with heart failure.
- Weight loss interventions, including bariatric surgery, offer significant benefits for heart failure patients.
- Addressing morbid obesity can lead to improved clinical outcomes and cardiac function.
Related Concept Videos
07:49A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
1.9K
The present protocol describes obtaining the pressure-volume relationship through transesophageal pacing, which serves as a valuable tool in evaluating diastolic function in mouse models of heart...
1.9K
01:29Heart Failure II: Pathophysiology
761
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
761
10:08Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
13.9K
Here, we present a protocol to produce tachycardia-induced cardiomyopathy in swine. This model represents a potent way to study the hemodynamics of progressive chronic heart failure and the effects of applied...
13.9K
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
711
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
711
05:08Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice
11.8K
The chronic administration of isoproterenol via an implanted osmotic pump has been used widely to mimic advanced heart failure in mice. Here, we describe detailed methods in surgical mini-pump implantation for the continuous isoproterenol administration over 3 weeks, as well as, echocardiographic assessment for the successful model...
11.8K